Literature DB >> 8866899

Ambulatory blood pressure normality: results from the PAMELA study.

G Mancia1, R Sega, C Bravi, G De Vito, F Valagussa, G Cesana, A Zanchetti.   

Abstract

OBJECTIVE: To determine ambulatory and home blood pressure means and distributions in relation to clinic blood pressure in a general population.
METHODS: We obtained a random sample of 2400 subjects stratified by sex and 10 year age groups to be representative of residents aged 25-64 years of the city of Monza. Participation rate was 69% (1651 subjects). Blood pressure measurements consisted of clinic blood pressure (average of three measurements, sphygmomanometry), home blood pressure (average of morning and evening measurements, semiautomatic device) and ambulatory blood pressure (automatic readings at 20 min intervals, Spacelabs 90207). Clinic blood pressure was obtained both before and after home and ambulatory blood pressures. Data analysis did not include 213 subjects receiving antihypertensive drug treatment and was therefore limited to 1438 participants.
RESULTS: In the 1438 subjects, clinic, home and ambulatory blood pressure showed a normal-like distribution, with a taller peak and a narrower base for ambulatory than for home and clinic values. Clinic, home and ambulatory blood pressures were significantly related to each other (P always < 0.001). The means of the two clinic blood pressures obtained on consecutive days were superimposable (127.4 +/- 17.0/82.3 +/- 9.8 and 128.2 +/- 16.5/81.9 +/- 9.9 mmHg) and both were markedly higher than home and 24 h average blood pressures (8.2 mmHg), which were similar to one another. The differences between clinic and home or 24 h average blood pressure were similar in both sexes but increased with increasing age and clinic blood pressure values. The influence of clinic blood pressure values on the clinic-ambulatory or clinic-home blood pressure differences was more important than age. Although higher than the 24 h average value, daytime average blood pressure was also lower than clinic blood pressure. Night-time blood pressure was markedly lower than the daytime value in both sexes and at all ages.
CONCLUSION: Data from a large and unbiased sample of a general population show that home and 24 h or daytime average blood pressures are much lower than clinic blood pressure. The relatively close correlation between blood pressure values measured with the different methods used has allowed calculation of home and ambulatory blood pressure values corresponding to the accepted upper limit of normality of clinic blood pressure (140/90 mmHg). The upper limit of normality for the population was for both home and ambulatory blood pressures in the range 120-130 and 75-81 mmHg for systolic and diastolic values, respectively, with slight differences depending on sex and age. Taking 140/90 mmHg as the upper normal limit of the population is therefore an error that leads to individuals whose home or ambulatory blood pressures are high being considered as normotensive.

Entities:  

Mesh:

Year:  1995        PMID: 8866899

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  61 in total

1.  Prevalence and determinants of white coat effect in a large UK hypertension clinic population.

Authors:  O Thomas; K E Shipman; K Day; M Thomas; U Martin; I Dasgupta
Journal:  J Hum Hypertens       Date:  2015-09-17       Impact factor: 3.012

2.  Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

Authors:  S Zacharieva; M Orbetzova; A Stoynev; R Shigarminova; M Yaneva; K Kalinov; E Nachev; A Elenkova
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 3.  Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring.

Authors:  Giuseppe Mancia; Gianfranco Parati
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 4.  Self-measurement of blood pressure at home in the management of hypertension.

Authors:  Hilde Celis; Elly Den Hond; Jan A Staessen
Journal:  Clin Med Res       Date:  2005-02

Review 5.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

6.  Diagnostic Thresholds for Blood Pressure Measured at Home in the Context of the 2017 Hypertension Guideline.

Authors:  Wanpen Vongpatanasin; Colby Ayers; Hamza Lodhi; Sandeep R Das; Jarett D Berry; Amit Khera; Ronald G Victor; Feng-Chang Lin; Anthony J Viera; Yuichiro Yano; James A de Lemos
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

7.  Rationale for Ambulatory and Home Blood Pressure Monitoring Thresholds in the 2017 American College of Cardiology/American Heart Association Guideline.

Authors:  Paul Muntner; Robert M Carey; Kenneth Jamerson; Jackson T Wright; Paul K Whelton
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

8.  Reflux nephropathy and hypertension: correlation with the progression of renal damage.

Authors:  Giuliana Lama; Michele Adolfo Tedesco; Luisa Graziano; Elvira Calabrese; Carolina Grassia; Francesco Natale; Giuseppe Pacileo; Pier Francesco Rambaldi; Maria Esposito-Salsano
Journal:  Pediatr Nephrol       Date:  2003-02-26       Impact factor: 3.714

Review 9.  Role of ambulatory blood pressure monitoring in resistant hypertension.

Authors:  Guido Grassi; Michele Bombelli; Gino Seravalle; Gianmaria Brambilla; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

10.  Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study.

Authors:  Geoffrey A Head; Anastasia S Mihailidou; Karen A Duggan; Lawrence J Beilin; Narelle Berry; Mark A Brown; Alex J Bune; Diane Cowley; John P Chalmers; Peter R C Howe; Jonathan Hodgson; John Ludbrook; Arduino A Mangoni; Barry P McGrath; Mark R Nelson; James E Sharman; Michael Stowasser
Journal:  BMJ       Date:  2010-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.